Publication Details
Abstract
Systemic Inflammatory Response Syndrome (SIRS) in infants is a life-threatening disease because of the immaturity of immune, cardiovascular and metabolic control systems during the first year of life. Systematic inflammatory response is especially difficult to detect at an early age, since the classical clinical manifestations, including fever, leukocytosis or hemodynamic instability, may be absent or poorly manifested in young children. Late diagnosis means that the patients have an increased risk of transition to serious complications, such as sepsis, dysfunction of multiple organs, and cardiovascular failure. The paper is devoted to the creation of a predictive model of the early diagnosis of SIRS in infants with the assistance of a complex of clinical risk factors and lab biomarkers. Emphasis is placed on the presence of inflammatory and coagulation markers like C- C-reactive protein, procalcitonin and D-dimer that indicate the severity of general inflammation and endothelial impairment. Perinatal history, maternal health, and neonatal analysis of the characteristics enable the identification of infants at risk of developing systemic inflammatory reactions. The suggested model of prognostics offers a sensible and objective instrument of risk stratification in infants with infectious diseases, especially pneumonia, at an early stage. Early identification of high-risk patients helps to start specialised therapeutic interventions promptly, such as close monitoring, antimicrobial treatment, and supportive care. The adoption of the mentioned predictive approach into clinical practice can help minimise infant mortality, avoid severe complications, and optimise the treatment approaches in paediatric intensive care units.